| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |